
About Immunifyme Healthcare Technologies Private Limited
Data last updated:
Immunifyme Healthcare Technologies Private Limited is a private limited company based in Gurgaon, Haryana, India. It operates in the hospital and clinical services segment of the healthcare sector. It was incorporated on 10 July 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85100HR2019PTC081395. Its GSTIN is 06AAFCI3371J1ZI (Haryana).
The company has an authorised share capital of ₹24.17 Cr and a paid-up capital of ₹24.05 Cr. It is led by directors including Nadeera Nilupamali Sirisena Pahala Dickwellage and Sudheera Lakmal Pahala Dickwellage.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 149 National Media Center Shankar Chowk, Gurgaon, Haryana, India – 122002.
The company has about 1 employee on its provident fund (EPFO) records.
The company is associated with 1 brand: ImmunifyMe.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website immunify.me.
Company details
Contact details
Immunifyme Healthcare Technologies Private Limited's registered office is in Gurgaon, Haryana. Its website is immunify.me. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address149 National Media Center Shankar Chowk, Gurgaon, Haryana, India – 122002
- IndustryHealthcare, Hospitals
To see the full contact details of Immunifyme Healthcare Technologies Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Immunifyme Healthcare Technologies operates one associated brand: ImmunifyMe. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Mobile application to track child vaccination records | immunifyme.com |
Business activity
The main business activity of Immunifyme Healthcare Technologies is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Immunifyme Healthcare Technologies Private Limited, buy the company report.
Financials of Immunifyme Healthcare Technologies Private Limited
FY 2025 filings availableImmunifyme Healthcare Technologies Private Limited reported revenue of ₹965 (down 100% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 72% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Immunifyme Healthcare Technologies Private Limited, buy the company report.
Board of directors of Immunifyme Healthcare Technologies Private Limited
Immunifyme Healthcare Technologies has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nadeera Nilupamali Sirisena Pahala Dickwellage | Director | 10 Jul 2019 | 7 Years 4 Months | Current |
| Sudheera Lakmal Pahala Dickwellage | Director | 10 Jul 2019 | 7 Years 4 Months | Current |
| Gouri Nilakantan Mehta Also directs: Immunifyme Healthcare Services LLP, Blue Bytes News Private Limited, Blue Lotus Communications (East) Private Limited and 5 more | Director | 01 Oct 2024 | 2 Years 1 Months | Current |
| Neeraj Kumar Mehta Also directs: Immunifyme Healthcare Services LLP, Purple Umbrella Foundation | Director | 10 Jul 2019 | 7 Years 4 Months | Current |
Auditor
Immunifyme Healthcare Technologies Private Limited is audited by V PANDEY & CO. for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V PANDEY & CO. | FY 2020 | 031772N |
Shareholding
The shareholding of Immunifyme Healthcare Technologies Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Immunifyme Healthcare Technologies Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Immunifyme Healthcare Technologies Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Immunifyme Healthcare Technologies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Immunifyme Healthcare Technologies Private Limited has a workforce of 1 employees on its EPFO records as of Jul 2023, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2023-24 | 1 |
| FY 2022-23 | |
| FY 2021-22 |
To see the full employee and EPFO history of Immunifyme Healthcare Technologies Private Limited, buy the company report.
GST
Immunifyme Healthcare Technologies has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAFCI3371J1ZI | Haryana | Active | 05 Oct 2019 |
To see the full GST registrations and return filing status of Immunifyme Healthcare Technologies Private Limited, buy the company report.
Recent activity
Immunifyme Healthcare Technologies Private Limited has 7 board changes on record since 2019: 4 appointments and 3 cessations. The latest: Gouri Nilakantan Mehta ceased to be Additional Director on 29 Sep 2025.
Frequently asked questions
Immunifyme Healthcare Technologies is an active private limited company based in Gurgaon, Haryana, India. The company works in hospitals, within the healthcare industry. It was incorporated on 10 July 2019 (7+ years old) and is registered under CIN U85100HR2019PTC081395.
Immunifyme Healthcare Technologies has 4 current directors:
- Nadeera Nilupamali Sirisena Pahala Dickwellage - Director
- Sudheera Lakmal Pahala Dickwellage - Director
- Gouri Nilakantan Mehta - Director
- Neeraj Kumar Mehta - Director
The latest financial statements of Immunifyme Healthcare Technologies on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Immunifyme Healthcare Technologies is 06AAFCI3371J1ZI, registered in Haryana.
The CIN (Corporate Identification Number) of Immunifyme Healthcare Technologies is U85100HR2019PTC081395. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Immunifyme Healthcare Technologies was incorporated on 10 July 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
Gouri Nilakantan Mehta ceased to be Additional Director on 29 Sep 2025. Nadeera Nilupamali Sirisena Pahala Dickwellage ceased to be Director on 04 Oct 2024. Sudheera Lakmal Pahala Dickwellage ceased to be Director on 04 Oct 2024. Immunifyme Healthcare Technologies has 7 board changes on record in total.
Immunifyme Healthcare Technologies can be reached through the website immunify.me. Its registered office is in Gurgaon, Haryana, India.
The registered office of Immunifyme Healthcare Technologies is at 149 National Media Center Shankar Chowk, Gurgaon, Haryana, India – 122002.
Immunifyme Healthcare Technologies operates in the healthcare industry, in the hospitals segment.

